| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0513 |
| Trial ID | NCT04213469 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Not Applicable |
| Recruitment status | Completed |
| Title | A Safety and Efficacy Evaluation of PD1-CD19-CART in Patients With Relapse/Refractory B-cell Lymphoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Bioray Laboratories |
| Other ID(s) | 2019-CAR-00CH1 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||||||||||
|
|||||||||||||||||||